Prescott Group Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$903K Buy
710,803
+397,518
+127% +$748K 0.09% 190
2025
Q4
$749K Buy
+313,285
New +$857K 0.07% 221

Other funds holding HCAT

Prescott Group Capital Management's HCAT Position: Q1 2026 in Review

Prescott Group Capital Management increased its Health Catalyst (HCAT) stake by 127% in Q1 2026, buying an estimated $748K and bringing the position to 710,803 shares worth $903K. The position accounts for 0.09% of the portfolio, ranked #190.

Prescott Group Capital Management first reported a position in HCAT in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Prescott Group Capital Management held 710,803 shares of Health Catalyst worth $903K as of Q1 2026.
  • Prescott Group Capital Management bought 397,518 Health Catalyst shares in Q1 2026, an estimated $748K.
  • Health Catalyst made up 0.09% of Prescott Group Capital Management's portfolio in Q1 2026, its #190 holding.
  • Prescott Group Capital Management first reported a position in Health Catalyst in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Prescott Group Capital Management's 13F filing for Q1 2026, filed 7 May 2026.